tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Molecular Partners AG (CH:MOLN)
:MOLN
Switzerland Market
MOLN
Molecular Partners AG
RESEARCH TOOLSreports

Molecular Partners AG (MOLN) Stock News & Sentiment

Compare
0 Followers
Molecular Partners Advances DLL3 Radioligand Program With New Phase 1/2a Cancer Trial
Premium
Company Announcements
Molecular Partners Advances DLL3 Radioligand Program With New Phase 1/2a Cancer Trial
26d ago
MLLCF
Promising Pipeline and Strategic Focus Drive Buy Rating for Molecular Partners
Premium
Ratings
Promising Pipeline and Strategic Focus Drive Buy Rating for Molecular Partners
2M ago
MOLN
Buy Rating for Molecular Partners: Innovative Pipeline and Promising SCLC Advancements
Premium
Ratings
Buy Rating for Molecular Partners: Innovative Pipeline and Promising SCLC Advancements
3M ago
MOLN
Molecular Partners: Promising Pipeline and Strategic Partnerships Justify Buy Rating
Premium
Ratings
Molecular Partners: Promising Pipeline and Strategic Partnerships Justify Buy Rating
3M ago
MOLN
Molecular Partners: Promising Pipeline and Financial Stability Justify Buy Rating Despite IND Delay
Premium
Ratings
Molecular Partners: Promising Pipeline and Financial Stability Justify Buy Rating Despite IND Delay
5M ago
MOLN
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
Premium
Ratings
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
5M ago
MOLN
Molecular Partners Reports H1 2025 Progress and Financial Stability
Premium
Company Announcements
Molecular Partners Reports H1 2025 Progress and Financial Stability
5M ago
More CH:MOLN News >

MOLN News on the Web

Molecular Partners AG conference call and Webcast Transcript
GuruFocus News
Neutral
Molecular Partners initiated with a Buy at H.C. Wainwright
TipRanks News
Bullish
Molecular Partners provided update on latest progress, 2026 milestones
TipRanks News
Bullish
Molecular Partners Advances DLL3 Radioligand Program With New Phase 1/2a Cancer Trial
TipRanks News
Bullish
Molecular Partners Reports H1 2025 Progress and Financial Stability
TipRanks News
Neutral
Molecular Partners (MOLN) Initiated with a Buy at LifeSci Capital
TipRanks News
Neutral
Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024
Yahoo Finance
Neutral
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
CH:MOLN
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CH:MOLN’s Media Buzz Sentiment?
1 articles about CH:MOLN were published this week. In an average week, 1 articles are published.
    What is CH:MOLN’s weekly average amount of articles?
    In an average week, 1 articles about CH:MOLN are published.
      What is CH:MOLN’s News Sentiment?
      50% of articles about CH:MOLN were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        DVADaVita
        TECHBio-Techne
        PLXProtalix
        VSTMVerastem
        RMDResmed
        Showing the stocks with the most bullish news sentiment over the past week